DYRK1A stabilizes HPV16E7 oncoprotein through phosphorylation of the threonine 5 and threonine 7 residues

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 11, 2008, Pages 2431-2441

  Liang, Yuh Jin ^a,b   Chang, Hung Shu ^c   Wang, Chen Yu ^d   Yu, Winston C Y ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

DYRK1A; E7; Human papillomavirus; Phosphorylation; Protein stability

Indexed keywords

DYRK 1A; ONCOPROTEIN; PHOSPHOTRANSFERASE; PROTEIN E7; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HALF LIFE TIME; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; IN VIVO STUDY; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RNA INTERFERENCE; STEADY STATE;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; ONCOGENE PROTEINS, VIRAL; PHOSPHORYLATION; POINT MUTATION; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RNA INTERFERENCE; THREONINE;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 48349087832     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.04.003     Document Type: Article

References (33)

1. Barbosa M.S., Edmonds C., Fisher C., Schiller J.T., Lowy D.R., and Vousden K.H. The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation. EMBO J 9 (1990) 153-160
2. Becker W., Weber Y., Wetzel K., Eirmbter K., Tejedor F.J., and Joost H.G. Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases. J Biol Chem 273 (1998) 25893-25902
3. Boyer S.N., Wazer D.E., and Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 56 (1996) 4620-4624
4. Campbell L.E., and Proud C.G. Differing substrate specificities of members of the DYRK family of arginine-directed protein kinases. FEBS Lett 510 (2002) 31-36
5. Chang H.S., Lin C.H., Yang C.H., Yen M.S., Lai C.R., Chen Y.R., et al. Increased expression of Dyrk1a in HPV16 immortalized keratinocytes enable evasion of apoptosis. Int J Cancer 120 (2007) 2377-2385
6. Ciechanover A., and Ben-Saadon R. N-terminal ubiquitination: more protein substrates join in. Trends Cell Biol 14 (2004) 103-106
7. de Graaf K., Czajkowska H., Rottmann S., Packman L.C., Lilischkis R., Luscher B., et al. The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site. BMC Biochem 7 (2006) 7
8. Dierssen M., and de Lagran M.M. DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A): a gene with dosage effect during development and neurogenesis. ScientificWorldJournal 6 (2006) 1911-1922
9. Firzlaff J.M., Galloway D.A., Eisenman R.N., and Luscher B. The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II. New Biol 1 (1989) 44-53
10. Galceran J., de Graaf K., Tejedor F.J., and Becker W. The MNB/DYRK1A protein kinase: genetic and biochemical properties. J Neural Transm Suppl (2003) 139-148
11. Gonzalez S.L., Stremlau M., He X., Basile J.R., and Munger K. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J Virol 75 (2001) 7583-7591
12. Guimera J., Casas C., Pucharcos C., Solans A., Domenech A., Planas A.M., et al. A human homologue of Drosophila minibrain (MNB) is expressed in the neuronal regions affected in Down syndrome and maps to the critical region. Hum Mol Genet 5 (1996) 1305-1310
13. Helt A.M., and Galloway D.A. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J Virol 75 (2001) 6737-6747
14. Helt A.M., and Galloway D.A. Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. Carcinogenesis 24 (2003) 159-169
15. Himpel S., Tegge W., Frank R., Leder S., Joost H.G., and Becker W. Specificity determinants of substrate recognition by the protein kinase DYRK1A. J Biol Chem 275 (2000) 2431-2438
16. Huang N.E., Lin C.H., Lin Y.S., and Yu W.C. Modulation of YY1 activity by SAP30. Biochem Biophys Res Commun 306 (2003) 267-275
17. Huh K., Zhou X., Hayakawa H., Cho J.Y., Libermann T.A., Jin J., et al. Human papillomavirus type 16 E7 oncoprotein associates with the cullin 2 ubiquitin ligase complex, which contributes to degradation of the retinoblastoma tumor suppressor. J Virol 81 (2007) 9737-9747 [Epub 2007 July 9733]
18. Jones D.L., Thompson D.A., and Munger K. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Virology 239 (1997) 97-107
19. Kamio M., Yoshida T., Ogata H., Douchi T., Nagata Y., Inoue M., et al. SOCS1 inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein. Oncogene 23 (2004) 3107-3115
20. Kanda T., Furuno A., and Yoshiike K. Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells. J Virol 62 (1988) 610-613
21. Kentrup H., Becker W., Heukelbach J., Wilmes A., Schurmann A., Huppertz C., et al. Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII. J Biol Chem 271 (1996) 3488-3495
22. Massimi P., and Banks L. Differential phosphorylation of the HPV-16 E7 oncoprotein during the cell cycle. Virology 276 (2000) 388-394
23. Munger K., Basile J.R., Duensing S., Eichten A., Gonzalez S.L., Grace M., et al. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20 (2001) 7888-7898
24. Munger K., and Howley P.M. Human papillomavirus immortalization and transformation functions. Virus Res 89 (2002) 213-228
25. Murakami N., Xie W., Lu R.C., Chen-Hwang M.C., Wieraszko A., and Hwang Y.W. Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome. J Biol Chem 281 (2006) 23712-23724
26. Oh K.J., Kalinina A., Wang J., Nakayama K., Nakayama K.I., and Bagchi S. The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase. J Virol 78 (2004) 5338-5346
27. Reinstein E., Scheffner M., Oren M., Ciechanover A., and Schwartz A. Degradation of the E7 human papillomavirus oncoprotein by the ubiquitin-proteasome system: targeting via ubiquitination of the N-terminal residue. Oncogene 19 (2000) 5944-5950
28. Selvey L.A., Dunn L.A., Tindle R.W., Park D.S., and Frazer I.H. Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines. J Gen Virol 75 Pt 7 (1994) 1647-1653
29. Smotkin D., and Wettstein F.O. The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol 61 (1987) 1686-1689
30. Song W.J., Sternberg L.R., Kasten-Sportes C., Keuren M.L., Chung S.H., Slack A.C., et al. Isolation of human and murine homologues of the Drosophila minibrain gene: human homologue maps to 21q22.2 in the Down syndrome "critical region". Genomics 38 (1996) 331-339
31. Wang C.Y., Liang Y.J., Lin Y.S., Shih H.M., Jou Y.S., and Yu W.C. YY1AP, a novel co-activator of YY1. J Biol Chem 279 (2004) 17750-17755
32. Wang J., Sampath A., Raychaudhuri P., and Bagchi S. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells. Oncogene 20 (2001) 4740-4749
33. Wang Y.W., Chang H.S., Lin C.H., and Yu W.C. HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity. Int J Biochem Cell Biol 39 (2007) 402-412